# Phase 3 shock trials recruiting: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 3 for shock that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 shock trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/shock

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07898462 | A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone... | The George Institute | Phase 3 | Recruiting | Septic Shock | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898462) |
| July 20, 2026 | NCT07714746 | Ivabradine in the Acute Management of Cardiogenic Shock | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 | Recruiting | Cardiogenic Shock Post Myocardial Infarction | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714746) |
| May 6, 2026 | NCT07569536 | Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock | Hospices Civils de Lyon | Phase 3 | Not yet recruiting | Septic Shock, Vasopressor Resistance | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569536) |
| March 23, 2026 | NCT07488689 | Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction | University Hospital, Strasbourg, France | Phase 3 | Not yet recruiting | Septic Shock | 568 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07488689) |
| October 8, 2025 | NCT07212582 | Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study) | Mahidol University | Phase 3 | Not yet recruiting | Critical Illness, Septic Shock | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07212582) |
| September 4, 2025 | NCT07155265 | REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults | Yancheng First People's Hospital | Phase 3 | Not yet recruiting | Critical Illness; Mechanical Ventilation; Shock | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07155265) |
| August 19, 2025 | NCT07129031 | Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock | Xijing Hospital | Phase 3 | Not yet recruiting | Hemorrhage, Hemorrhagic Shock, Upper Gastrointestinal Bleeding (UGIB) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07129031) |
| August 1, 2025 | NCT07099014 | Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Cardiogenic Shock, ECMO | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07099014) |
| July 16, 2025 | NCT07067866 | Weaning Approaches for Vasopressin in Sepsis | Hospital Nossa Senhora da Conceicao | Phase 3 | Recruiting | Septic Shock | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07067866) |
| July 14, 2025 | NCT07063095 | A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected... | Sponsor not shown (see the record) | Phase 3 | Recruiting | Gram Negative Infections, Sepsis and Septic Shock | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07063095) |
| July 4, 2025 | NCT07052084 | Systematic Adjunction of Vasopressine in Septic Shock | Assistance Publique Hopitaux De Marseille | Phase 3 | Recruiting | Septic Shock | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07052084) |
| February 28, 2025 | NCT06851078 | Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Septic Shock | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06851078) |
| November 20, 2024 | NCT06696391 | Venous Excess Ultrasound for Personalized Resuscitation in Septic Shock | Western University, Canada | Phase 3 | Not yet recruiting | Septic Shock, Sepsis, Shock, Critical Care, Intensive Care, Resuscitation | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06696391) |
| June 18, 2024 | NCT06464510 | Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis | Hospital do Coracao | Phase 3 | Recruiting | Septic Shock | 2,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06464510) |
| October 6, 2023 | NCT06070350 | Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children | Sponsor not shown (see the record) | Phase 3 | Recruiting | Hemorrhagic Shock, Trauma Injury | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06070350) |
| July 5, 2023 | NCT05931601 | Early Initiated Vasopressor Therapy in the Emergency Department | Odense University Hospital | Phase 3 | Recruiting | Shock, Shock, Septic, Hypotension, Hypotension and Shock, Hypotension Symptomatic, Hypovolemia, Hypovolemic Shock... | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05931601) |
| May 30, 2023 | NCT05879276 | Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular... | Central Hospital, Nancy, France | Phase 3 | Recruiting | Cardiogenic Shock | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05879276) |
| June 29, 2022 | NCT05437575 | Prehospital Analgesia INtervention Trial (PAIN) | Sponsor not shown (see the record) | Phase 3 | Recruiting | Traumatic Injury | 994 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05437575) |
| February 22, 2022 | NCT05251181 | A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent | Pharmazz, Inc. | Phase 3 | Not yet recruiting | Hypovolemic Shock | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05251181) |
| June 18, 2021 | NCT04931225 | LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS) | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | Septic Shock | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04931225) |
| February 11, 2021 | NCT04750070 | Management of Shock in Children With SAM or Severe Underweight and Diarrhea | International Centre for Diarrhoeal Disease Research, Bangladesh | Phase 3 | Recruiting | Shock Hypovolemic, Shock, Septic, Blood Transfusion, Adrenaline, Dopamine | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04750070) |
| February 10, 2021 | NCT04748796 | Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With... | Centre Hospitalier Universitaire, Amiens | Phase 3 | Recruiting | Septic Shock, Tachycardia, Mortality During Septic Shock, Beta-blocker | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04748796) |
| July 16, 2019 | NCT04020263 | Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality... | Sponsor not shown (see the record) | Phase 3 | Recruiting | Cardiogenic Shock | 610 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04020263) |
| January 17, 2018 | NCT03401398 | Stress Hydrocortisone In Pediatric Septic Shock | Sponsor not shown (see the record) | Phase 3 | Recruiting | Septic Shock | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03401398) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Western University, Canada | 1 |
| Hospital do Coracao | 1 |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 1 |
| Xijing Hospital | 1 |
| Hospital Nossa Senhora da Conceicao | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| The George Institute | 1 |
| University Hospital, Strasbourg, France | 1 |
| Mahidol University | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Pharmazz, Inc. | 1 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| Odense University Hospital | 1 |
| Yancheng First People's Hospital | 1 |
| Hospices Civils de Lyon | 1 |

## By country

| Country | Trials |
| --- | --- |
| France | 7 |
| Brazil | 3 |
| United States | 3 |
| Canada | 2 |
| Pakistan | 2 |
| Bangladesh | 1 |
| China | 1 |
| Israel | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
| Vietnam | 1 |
| Australia | 1 |
| Thailand | 1 |
| Denmark | 1 |
| Sweden | 1 |
| Switzerland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Plastic manufacturers in the United States](https://specstream.ai/data/businesses/plastic-manufacturers/united-states)
- [Hot dog restaurants in the United States](https://specstream.ai/data/businesses/hot-dog-restaurants/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [Wholesale grocers in the United States](https://specstream.ai/data/businesses/wholesale-grocers/united-states)
- [Primary care clinics in the United States](https://specstream.ai/data/businesses/primary-care-clinics/united-states)
- [Import and export companies in the United States](https://specstream.ai/data/businesses/import-and-export-companies/united-states)
